Lab Reagents
Binding Assay Laboratories manufactures the assay menu the binding site reagents distributed by Genprice. The Assay Menu The Binding Site reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact binding assay. Other Assay products are available in stock. Specificity: Assay Category: Menu Group: The Binding
The Binding information
EBAG9 Antibody / Estrogen Receptor Binding Site Associated Antigen 9 |
V8199-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: EBAG9, also known as RCAS1, is an estrogen-transcribed protein. Soluble and membranous RCAS1 proteins may play a role in the immune escape of tumor cells by promoting T lymphocyte inhibition of growth and apoptosis. RCAS1 is expressed in a wide variety of cancers, including uterine, ovarian, and lung cancer cells, and acts as a ligand for a putative receptor present on peripheral lymphocytes. RCAS1 is highly expressed not only in cancer cells but also in non-tumor bile duct cells subject to immune attack. RCAS1 inhibits the in vitro growth of receptor-expressing cells and induces apoptosis, contributing to the ability of tumor cells to evade host immune surveillance. High expression of RCAS1 significantly correlates with tumor progression and with poor outcome for many cancer patients. |
EBAG9 Antibody / Estrogen Receptor Binding Site Associated Antigen 9 |
V8199SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: EBAG9, also known as RCAS1, is an estrogen-transcribed protein. Soluble and membranous RCAS1 proteins may play a role in the immune escape of tumor cells by promoting T lymphocyte inhibition of growth and apoptosis. RCAS1 is expressed in a wide variety of cancers, including uterine, ovarian, and lung cancer cells, and acts as a ligand for a putative receptor present on peripheral lymphocytes. RCAS1 is highly expressed not only in cancer cells but also in non-tumor bile duct cells subject to immune attack. RCAS1 inhibits the in vitro growth of receptor-expressing cells and induces apoptosis, contributing to the ability of tumor cells to evade host immune surveillance. High expression of RCAS1 significantly correlates with tumor progression and with poor outcome for many cancer patients. |
EBAG9 Antibody / Estrogen Receptor Binding Site Associated Antigen 9 |
V8200-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: EBAG9, also known as RCAS1, is an estrogen-transcribed protein. Soluble and membranous RCAS1 proteins may play a role in the immune escape of tumor cells by promoting T lymphocyte inhibition of growth and apoptosis. RCAS1 is expressed in a wide variety of cancers, including uterine, ovarian, and lung cancer cells, and acts as a ligand for a putative receptor present on peripheral lymphocytes. RCAS1 is highly expressed not only in cancer cells but also in non-tumor bile duct cells subject to immune attack. RCAS1 inhibits the in vitro growth of receptor-expressing cells and induces apoptosis, contributing to the ability of tumor cells to evade host immune surveillance. High expression of RCAS1 significantly correlates with tumor progression and with poor outcome for many cancer patients. |
EBAG9 Antibody / Estrogen Receptor Binding Site Associated Antigen 9 |
V8200-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: EBAG9, also known as RCAS1, is an estrogen-transcribed protein. Soluble and membranous RCAS1 proteins may play a role in the immune escape of tumor cells by promoting T lymphocyte inhibition of growth and apoptosis. RCAS1 is expressed in a wide variety of cancers, including uterine, ovarian, and lung cancer cells, and acts as a ligand for a putative receptor present on peripheral lymphocytes. RCAS1 is highly expressed not only in cancer cells but also in non-tumor bile duct cells subject to immune attack. RCAS1 inhibits the in vitro growth of receptor-expressing cells and induces apoptosis, contributing to the ability of tumor cells to evade host immune surveillance. High expression of RCAS1 significantly correlates with tumor progression and with poor outcome for many cancer patients. |
EBAG9 Antibody / Estrogen Receptor Binding Site Associated Antigen 9 |
V8200SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: EBAG9, also known as RCAS1, is an estrogen-transcribed protein. Soluble and membranous RCAS1 proteins may play a role in the immune escape of tumor cells by promoting T lymphocyte inhibition of growth and apoptosis. RCAS1 is expressed in a wide variety of cancers, including uterine, ovarian, and lung cancer cells, and acts as a ligand for a putative receptor present on peripheral lymphocytes. RCAS1 is highly expressed not only in cancer cells but also in non-tumor bile duct cells subject to immune attack. RCAS1 inhibits the in vitro growth of receptor-expressing cells and induces apoptosis, contributing to the ability of tumor cells to evade host immune surveillance. High expression of RCAS1 significantly correlates with tumor progression and with poor outcome for many cancer patients. |
The Cryo Combination |
M-MD1-94 |
MiTeGen |
79 x 1.5 ml ml |
EUR 506 |
|
Description: The Cryo Combination |
The Berkeley Screen |
M-R-1020947 |
MiTeGen |
1 KIT |
EUR 316 |
|
Description: The Berkeley Screen |
Human Anti-Chicken egg ovotransferrin (Gal d 3, IgE ELISA Kit, 96 tests, Quantitative |
610-255-THE |
Alpha Diagnostics |
1 Kit |
EUR 1000.8 |
HIF-1 Alpha DNA Binding Activity Assay Kit |
CBA-282 |
Cell Biolabs |
96 assays |
EUR 762 |
Description: Cell Biolabs? HIF-1 Alpha DNA Binding Activity Assay Kit is an immunoassay developed for rapid detection of activated HIF-1 in any protein sample. Active HIF-1 complex is captured on a double stranded oligonucleotide containing an HRE that is attached to the well. HIF-1 Alpha is then detected with an anti-HIF-1 Alpha antibody followed by an HRP conjugated secondary antibody. Each kit provides sufficient reagents to perform up to a total of 96 assays, and can detect HIF-1 Alpha from human, mouse, or rat. The HIF-1 DNA Binding Activity Assay takes only 4.5 hours to complete compared to a standard 3 day electromobility shift (EMSA) method. |
Hamster Thyroxine-Binding Globulin Assay,TBG ELISA Kit |
CN-00085O1 |
ChemNorm |
96T |
EUR 573.6 |
Hamster Thyroxine-Binding Globulin Assay,TBG ELISA Kit |
CN-00085O2 |
ChemNorm |
48T |
EUR 394.8 |
Human Thyroxine-Binding Globulin Assay,TBG ELISA Kit |
CN-04286H1 |
ChemNorm |
96T |
EUR 536.4 |
Human Thyroxine-Binding Globulin Assay,TBG ELISA Kit |
CN-04286H2 |
ChemNorm |
48T |
EUR 355.2 |
Human Thyroxine-Binding Globulin Assay(TBG)ELISA Kit |
GA-E0084HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human Thyroxine-Binding Globulin Assay(TBG)ELISA Kit |
GA-E0084HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human Thyroxine-Binding Globulin Assay,TBG ELISA Kit |
201-12-0029 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |